Evoke Pharma, Inc. (EVOK) Financials

Stock symbol EVOK is outdated, potentially delisted? Maybe it is available on other exchange?

EVOK Assets vs Liabilities

Date	Assets	Liabilities
June 30, 2025	16.1 million	11.7 million
March 31, 2025	16.4 million	10.5 million
Dec. 31, 2024	17.5 million	10.5 million
Sept. 30, 2024	14.2 million	9.8 million

EVOK Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
June 30, 2025	-565018	104253
March 31, 2025	-997509	84384
Dec. 31, 2024	-1.2 million	260927
Sept. 30, 2024	-818690	131587

EVOK Net Income

No data available :(

EVOK Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
June 30, 2025	12.1 million	65028	128797
March 31, 2025	12.6 million	83217	144842
Dec. 31, 2024	13.6 million	100958	160491
Sept. 30, 2024	11.3 million	-	-

EVOK Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
June 30, 2025	2.6 million
March 31, 2025	2.5 million
Dec. 31, 2024	1.5 million
Sept. 30, 2024	1.4 million

EVOK Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
June 30, 2025	-	8413	5.1 million	-
March 31, 2025	-	42783	4.3 million	-
Dec. 31, 2024	-	16.3 billion	4.4 million	-
Sept. 30, 2024	5	11677	3.8 million	-

EVOK Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
June 30, 2025	3.8 million	167679
March 31, 2025	3.1 million	41613
Dec. 31, 2024	3.3 million	118500
Sept. 30, 2024	2.7 million	104024

EVOK Revenue by Segment

Graph available only for paid members. Upgrade to see it.

EVOK

Price: $11

52 week price:

1.94

11.00

Earnings Per Share: -1.38 USD

P/E Ratio: -7.92

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 13353

Ebitda: -3.7 million

Market Capitalization: 18.8 million

Links:

EVOK on Yahoo Finance